Tolera Therapeutics
Kalamazoo, US · 1 known investors
Find your way into Tolera Therapeutics
Sign up to see every warm intro you have to Tolera Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tolera Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AP
Ashleigh PalmerExecutive
Board
MO
Mark OlesnavageBoard director
SD
Suzette DutchBoard director
DP
Donald ParfetBoard director
DM
Douglas MortonBoard director
Investors · 1
Triathlon Medical Venture Partnersreported
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2014
▶$250KraisedSep 2014 · 2 investors · PharmaceuticalsRule 506(b)
▶$250KraisedSep 2014 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Douglas MortonDirector
- Mark OlesnavageDirector
- Suzette DutchDirector
- Donald ParfetDirector
- Ashleigh PalmerExecutive Officer
- Amount sold
- $250K
- Minimum investment
- $1K
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Tolera Therapeutics's investors?
- Tolera Therapeutics's investors include Triathlon Medical Venture Partners.
- How much funding has Tolera Therapeutics raised?
- Tolera Therapeutics has disclosed $250K raised across 1 round.
- Where is Tolera Therapeutics headquartered?
- Tolera Therapeutics is headquartered in Kalamazoo, US.